A new therapy for systemic sclerosis-associated interstitial disease

被引：0
|
作者：
Kondoh, Yasuhiro [1 ]
机构：
[1] Nagoya Univ, Sch Med, Dept Resp Med & Allergy, Tosei Gen Hosp, 160 Nishioiwake Cho, Seto, Aichi 4898642, Japan
来源：
RESPIRATORY INVESTIGATION | 2020年 / 58卷 / 04期
关键词：
Cyclophosphamide; Nintedanib; Systemic sclerosis; Interstitial lung disease; Mycophenolate; LUNG-DISEASE; CYCLOPHOSPHAMIDE; DEATH;
D O I：
10.1016/j.resinv.2020.03.005
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：227 / 229
页数：3
相关论文
共 50 条
  • [41] SERUM METABOLITES AS BIOMARKERS IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Meier, C.
    Freiburghaus, K.
    Bovet, C.
    Schniering, J.
    Distler, O.
    Nakas, C.
    Maurer, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1108 - 1108
  • [42] Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
    Volkmann, Elizabeth R.
    Wilhalme, Holly
    Tashkin, Donald P.
    Kim, Grace Hyun J.
    Goldin, Jonathan
    Haussmann, Alana
    Kuwana, Masataka
    Roth, Michael D.
    Assassi, Shervin
    ARTHRITIS CARE & RESEARCH, 2025,
  • [43] B cell infiltration in systemic sclerosis-associated interstitial lung disease
    Lafyatis, Robert
    O'Hara, Carl
    Feghali-Bostwick, Carol A.
    Matteson, Eric
    ARTHRITIS AND RHEUMATISM, 2007, 56 (09): : 3167 - 3168
  • [44] Systemic sclerosis-associated interstitial lung disease: Role of the oesophagus in outcomes
    Strek, Mary E.
    RESPIROLOGY, 2018, 23 (10) : 885 - 886
  • [45] Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
    Volkmann, Elizabeth
    Wilhalme, Holly
    Tashkin, Donald
    Kim, Grace
    Goldin, Jonathan
    Haussmann, Alana
    Kuwana, Masataka
    Roth, Michael
    Assassi, Shervin
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3448 - 3449
  • [46] Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease
    Montesi, Sydney B.
    Caravan, Peter
    CURRENT RHEUMATOLOGY REPORTS, 2019, 21 (06)
  • [47] Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus
    Sumida, Hayakazu
    Asano, Yoshihide
    Tamaki, Zenshiro
    Aozasa, Naohiko
    Taniguchi, Takashi
    Takahashi, Takehiro
    Toyama, Tetsuo
    Ichimura, Yohei
    Noda, Shinji
    Akamata, Kaname
    Miyazaki, Miki
    Kuwano, Yoshihiro
    Yanaba, Koichi
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2014, 41 (05): : 418 - 420
  • [48] Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
    Hoffmann-Vold, Anna-Maria
    Allanore, Yannick
    Alves, Margarida
    Brunborg, Cathrine
    Airo, Paolo
    Ananieva, Lidia P.
    Czirjak, Laszlo
    Guiducci, Serena
    Hachulla, Eric
    Li, Mengtao
    Mihai, Carina
    Riemekasten, Gabriela
    Sfikakis, Petros P.
    Kowal-Bielecka, Otylia
    Riccardi, Antonella
    Distler, Oliver
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (02) : 219 - 227
  • [49] Oesophageal diameter is associated with severity but not progression of systemic sclerosis-associated interstitial lung disease
    Winstone, Tiffany A.
    Hague, Cameron J.
    Soon, Jeanette
    Sulaiman, Nada
    Murphy, Darra
    Leipsic, Jonathon
    Dunne, James V.
    Wilcox, Pearce G.
    Ryerson, Christopher J.
    RESPIROLOGY, 2018, 23 (10) : 921 - 926
  • [50] Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
    Elhai, Muriel
    Hoffmann-Vold, Anna Maria
    Avouac, Jerome
    Pezet, Sonia
    Cauvet, Anne
    Leblond, Agathe
    Fretheim, Havard
    Garen, Torhild
    Kuwana, Masataka
    Molberg, Oyvind
    Allanore, Yannick
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (06) : 972 - 982
12345